Robert L. Ferrara, Director at Phio Pharmaceuticals Corp. (PHIO), bought 5,000 shares at $0.41 ($2K) on 2022-12-02, disclosed to the SEC on 2022-12-05.
Open-market purchase of $2k PHIO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| PHIO | BUY | 2023-06-15 | $6K | — | Filing → |
| PHIO | BUY | 2022-11-28 | $820 | — | Filing → |
| PHIO | BUY | 2021-03-03 | $2K | — | Filing → |